Methylone for the Treatment for PTSD: Initial Results From an Open-Label Study (IMPACT-1)

被引：0
|
作者：
Jones, Amanda [1 ]
Warner-Schmidt, Jennifer [1 ]
Stogniew, Martin [1 ]
Mandell, Blake [1 ]
Kwak, Hannah [1 ]
Miller, Paul W. [1 ]
Ching, Terence H. W. [1 ]
Averill, Lynnette [1 ]
Kelmendi, Benjamin [1 ]
机构：
[1] Transcend Therapeut, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Methylone; PTSD; Transcend Therapeutics; Human; Clinical Trial;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P26
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [31] Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
    Thakur, CP
    Kanyok, TP
    Pandey, AK
    Sinha, GP
    Messick, C
    Olliaro, P
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (04) : 432 - 433
  • [32] Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care
    Castera, Philippe
    Stewart, Edmund
    Grosskopf, Josef
    Brotons, Carlos
    Schou, Maiken Brix
    Zhang, Doris
    Brach, Bjorn Steiniger
    Meulien, Didier
    EUROPEAN ADDICTION RESEARCH, 2018, 24 (06) : 293 - 303
  • [33] Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
    Thompson, Richard J.
    Artan, Reha
    Baumann, Ulrich
    Calvo, Pier Luigi
    Czubkowski, Piotr
    Dalgic, Buket
    D'Antiga, Lorenzo
    Di Giorgio, Angelo
    Durmaz, Ozlem
    Gonzales, Emmanuel
    Grammatikopoulos, Tassos
    Gupte, Girish
    Hardikar, Winita
    Houwen, Roderick H. J.
    Kamath, Binita M.
    Karpen, Saul J.
    Lacaille, Florence
    Lachaux, Alain
    Lainka, Elke
    Loomes, Kathleen M.
    Mack, Cara L.
    Mattsson, Jan P.
    Mckiernan, Patrick
    Ni, Quanhong
    Ozen, Hasan
    Rajwal, Sanjay R.
    Roquelaure, Bertrand
    Shteyer, Eyal
    Sokal, Etienne
    Sokol, Ronald J.
    Soufi, Nisreen
    Sturm, Ekkehard
    Tessier, Mary Elizabeth
    van der Woerd, Wendy L.
    Verkade, Henkjan J.
    Vittorio, Jennifer M.
    Wallefors, Terese
    Warholic, Natalie
    Yu, Qifeng
    Horn, Patrick
    Kjems, Lise
    JHEP REPORTS, 2023, 5 (08)
  • [34] Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label Study
    Gotkine, Marc
    Schoenfeld, David A.
    Cohen, Ilana
    Shefner, Jeremy M.
    Lerner, Yossef
    Cohen, Irun R.
    Klein, Colin
    Ovadia, Eran
    Cudkowicz, Merit E.
    Pooled Resource Open-Access ALS Clinical Trials Consortium
    MUSCLE & NERVE, 2025,
  • [35] A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia
    Vivash, Lucy
    Malpas, Charles B.
    Meletis, Christian
    Gollant, Meghan
    Eratne, Dhamidhu
    Li, Qiao-Xin
    McDonald, Stuart
    O'Brien, William T.
    Brodtmann, Amy
    Darby, David
    Kyndt, Christopher
    Walterfang, Mark
    Hovens, Christopher M.
    Velakoulis, Dennis
    O'Brien, Terence J.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [36] Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
    Pivonello, Rosario
    Bancos, Irina
    Feelders, Richard A. A.
    Kargi, Atil Y. Y.
    Kerr, Janice M. M.
    Gordon, Murray B. B.
    Mariash, Cary N. N.
    Terzolo, Massimo
    Ellison, Noel
    Moraitis, Andreas G. G.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [37] Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
    Klein, Brad C.
    Miceli, Rosa
    Severt, Lawrence
    McAllister, Peter
    Mechtler, Laszlo
    McVige, Jennifer
    Diamond, Merle
    Marmura, Michael J.
    Guo, Hua
    Finnegan, Michelle
    Trugman, Joel M.
    CEPHALALGIA, 2023, 43 (01)
  • [38] Responses to Adalimumab in Patients with Active Psoriatic Arthritis Who Have Not Adequately Responded to Prior Therapy: Effectiveness and Safety Results From an Open-label Study
    Gladman, Dafna D.
    Sampalis, John S.
    Illouz, Olivier
    Guerette, Benoit
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (09) : 1898 - 1906
  • [39] Impact of Prospectively Determined A118G Polymorphism on Treatment Response to Injectable Naltrexone Among Methamphetamine-Dependent Patients: An Open-Label, Pilot Study
    Pal, Reshmi
    Mendelson, John E.
    Flower, Keith
    Garrison, Kathleen
    Yount, Garret
    Coyle, Jeremy R.
    Galloway, Gantt P.
    JOURNAL OF ADDICTION MEDICINE, 2015, 9 (02) : 130 - 135
  • [40] Treatment of growth failure with growth hormone in children with chronic kidney disease: an open-label long-term study
    Mueller-Wiefel, D.
    Frisch, H.
    Tulassay, T.
    Bell, L.
    Zadik, Z.
    CLINICAL NEPHROLOGY, 2010, 74 (02) : 97 - 105
12345